Honokiol liposome lyophilized powder for injection (Jinrui Foundation)

注射用和厚朴酚脂质体冻干粉（金瑞基业）

Report date: 2025/08/27 14:41:53
NME

Base Information

Drug NameHonokiol liposome lyophilized powder for injection (Jinrui Foundation)
Drug Alias NameJRF-101
ClassificationNatural product/ExtractSmall molecules > Heterocyclic drugs
Mechanisms of ActionForkhead box protein M1 inhibitorsImmunomodulators
TargetsForkhead box protein M1
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungMeningioma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesChengdu Jinrui Foundation Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Jinrui Foundation Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungMeningioma +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG